PACT for Individuals With Serious Mental Illness (SMI-PACT)
People with serious mental illness have difficulty making good use of primary care, and die, on average, years earlier than others in the population. The greatest contributors to this premature mortality are medical illnesses, especially cardiovascular disease and cancer. The Patient Centered Medical Home is a model for reorganizing primary care practice so that healthcare is more effective, efficient, and user-friendly. It is being implemented across VA as the, "Patient Aligned Care Team" (PACT). It is unclear, however, how this PACT model applies to people whose predominant illness is treated by specialists. This is the case for people with serious mental illness (SMI), many of whom require ongoing treatment at mental health clinics. To achieve optimal health outcomes in the population with SMI, it may be necessary to adapt the PACT model so that it includes approaches that have proven to improve healthcare in this population. This project implements an adapted "SMI-PACT" model at two VA healthcare centers, and evaluates its effect on veterans with SMI.
Schizophrenia and Disorders With Psychotic Feature
Other: Patient Aligned Care Team (PACT)
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||PACT to Improve Health Care in People With Serious Mental Illness (SMI-PACT)|
- Composite Prevention Score [ Time Frame: 15-months ] [ Designated as safety issue: No ]Preventive score is calculated based on the Office of Quality and Performance Technical Manual and uses the following data: pneumococcal immunization age 65 and older, ever received; Influenza vaccination 50-64 years of age; Influenza vaccination 65+ years of age; % of women age 50-69 screened for breast cancer; % of women age 21-64 screened for cervical cancer in the past three years; % of patients receiving appropriate colorectal cancer screening; % of patients screened for obesity
- Composite Diabetes Mellitus Score [ Time Frame: 15-months ] [ Designated as safety issue: No ]Diabetes Mellitus score is calculated based on the Office of Quality and Performance Technical Manual and uses the following data: LDL-C < 100 mg/Dl; HbA1c Annual; HbA1c >9 or not done (poor control) in past year; Retinal Exam, timely by disease; LDL Measured; BP < 140/90; Nephropathy screening test or evidence of nephropathy
- medical and mental health treatment utilization and cost [ Time Frame: 15-months ] [ Designated as safety issue: No ]
- Assess acceptability of the SMI-PACT model, and barriers and facilitators to its implementation [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Investigate the relationships between organizational context, intervention factors, and patient and provider outcomes [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Identify factors related to successful patient outcomes [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- VA Decision Support System National Database Extracts (DSS NDEs) [ Time Frame: 15 months ] [ Designated as safety issue: No ]Using DSS NDE data and using microcosting methods we will determine healthcare costs
- Assessment of Chronic Illness Care (ACIC) [ Time Frame: 15 months ] [ Designated as safety issue: No ]organizational impacts of SMI-PACT vs usual care; strengths and weaknesses in care for chronic illnesses; 28-items
- patient Assessment of Chronic Illness Care (PACIC) [ Time Frame: 15 months ] [ Designated as safety issue: No ]Assesses the extent to which patients with chronic illness receive care that aligns with the Chronic Care Model; 20-items; gathered from patients
- Rogers' Adoption Questionnaire [ Time Frame: 15-months ] [ Designated as safety issue: No ]assesses three factors that potentially affect rate of adoption: complexity, relative advantage, and observability; 20-items
- Maslach Burnout Inventory (MBI) [ Time Frame: 15-months ] [ Designated as safety issue: No ]Measure aspects of workplace stress and has three subscales: emotional exhaustion, depersonalization, and personal accomplishments
- Behavior and Symptom Identification Scale - Revised (BASIS-R) [ Time Frame: 15-months ] [ Designated as safety issue: No ]measures psychopathology, and provides covariates for analyses. We will use the following scales: psychosis (4 items), depression/daily functioning (6 items), interpersonal functioning (5 items), and alcohol/drug use (4 items)
- Ambulatory Care Experiences Survey (ACES; Short Form) [ Time Frame: 15-months ] [ Designated as safety issue: No ]Evaluates patients' experiences with a specific physician and that physician's practice. The ACES uses the Institute of Medicine definition of primary care as its underlying conceptual model for measurement, but was designed to evaluate any sustained clinician-patient relationship, irrespective of clinical specialty. It is sensitive to changes in patients' experiences of care over time
- Interpersonal Support Evaluation List (ISEL) [ Time Frame: 15-months ] [ Designated as safety issue: No ]30-item instrument that assesses perceptions of social support, including: belonging, appraisal help, tangible support, and self-esteem support
- Medication Possession Ratio (MPR) [ Time Frame: 15-months ] [ Designated as safety issue: No ]MPR assesses the extent to which dispensed medications provide coverage for a given interval. It has been shown to be a valid measure of adherence in people with SMI
- Ethnographic field notes [ Time Frame: 15-months ] [ Designated as safety issue: No ]Will be taken by the Evaluation Lead throughout implementation to capture aspects of the inner setting and otherwise unmeasured aspects of usual care.
- Semi-structured qualitative interviews [ Time Frame: 15-months ] [ Designated as safety issue: No ]Baseline assessment will include an examination of usual practices, and knowledge, attitudes, and behaviors regarding medical care of patients with SMI. Staff at intervention sites will be asked about their expectations for SMI-PACT, and anticipated barriers and facilitators to implementation. The mid-study and final follow-up will interviews will assess: (1) usual care versus SMI-PACT; (2) barriers and facilitators to implementation of SMI-PACT (intervention staff); (3) provider perceptions of acceptability of SMI-PACT (intervention staff).
|Study Start Date:||October 2014|
|Estimated Study Completion Date:||December 2018|
|Estimated Primary Completion Date:||March 2017 (Final data collection date for primary outcome measure)|
Patient Aligned Care Team (PACT) model to address the physical healthcare needs for individuals with serious mental illness
Other: Patient Aligned Care Team (PACT)
A integrated healthcare model to coordinate and address physical health needs. The PACT model to be implemented here will be specially designed for individuals with serious mental illness.
Other Name: SMI-PACT
No Intervention: Usual Care
People with serious mental illness (SMI) die, on average, many years prematurely, with rates of premature mortality 2 to 3 times greater than the general population. Over 60% of premature deaths in this population are due to "natural causes," especially poorly treated cardiovascular, respiratory, and infectious diseases. Although the VA is a centrally organized, comprehensive healthcare system, veterans with SMI still have difficulty navigating the system, and are at substantially elevated risk for premature death. Too often, they do not attend scheduled appointments or fail to engage in primary care treatment, and consequently do not get valuable preventive and primary care services.
Primary care in VA has undergone significant transformation under the Patent Aligned Care Team (PACT) model, which is based on the Patient Centered Medical Home (PCMH) concept. PACT has the goal of improving the quality, efficiency, and patient-centeredness of primary care. But it remains unclear how PACT will impact the large populations of veterans who get the majority of their care in specialty settings, such as people with SMI. Research can inform efforts to apply the PACT model in specialty settings. For example, while people with SMI do poorly with usual primary care arrangements, there is now substantial evidence that integrated care and medical care management approaches can improve medical treatment and outcomes, and reduce treatment costs, in people with SMI.
Using available evidence, we propose to implement and evaluate a specialized PACT model that meets the needs of individuals with SMI ("SMI-PACT").
This project will partner with leadership at two medical centers to implement SMI-PACT, with the goal of improving healthcare and outcomes among people with SMI, while reducing unnecessary use of emergency and hospital services. Evidence-based quality improvement strategies will be used to reorganize processes of care. In a site-level controlled trial, this project will evaluate the effect, relative to usual care, of SMI-PACT implementation on (a) provision of appropriate preventive and medical treatments; (b) patient health-related quality of life and satisfaction with care; and (c) medical and mental health treatment utilization and costs. The project includes a mixed methods formative evaluation of usual care and SMI-PACT implementation to strengthen the intervention, and assess barriers and facilitators to its implementation. Mixed methods will also be used to investigate the relationships between organizational context, intervention factors, and patient and provider outcomes; and identify patient factors related to successful patient outcomes.
This project's approach to SMI-PACT is consistent with the VA PACT model, and with efforts in VA to improve care for veterans with psychiatric disorders. This will be one of the first projects to systematically implement and evaluate the PCMH and PACT concepts beyond primary care. Should SMI-PACT be demonstrated to be feasible and effective, the model could be used more broadly to improve the quality and efficiency of care for veterans with serious mental illness. Findings regarding PACT in specialty mental health may also inform efforts to improve care in other specialty healthcare settings.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01668355
|Contact: Alexander S Young, MD MSHS||(310) 268-3416||Alexander.Young@va.gov|
|Contact: Amy N Cohen, PhD||(310) 478-3711 ext 40770||Amy.Cohen@va.gov|
|United States, California|
|VA Greater Los Angeles Healthcare System, West Los Angeles, CA||Not yet recruiting|
|West Los Angeles, California, United States, 90073|
|Contact: Alexander S Young, MD MSHS 310-268-3416 Alexander.Young@va.gov|
|Contact: Rebecca Obermann (310) 478-3711 ext 48165 Rebecca.Oberman@va.gov|
|Sub-Investigator: Amy N. Cohen, PhD|
|Principal Investigator:||Alexander Stehle Young, MD MSHS||VA Greater Los Angeles Health Care System|